FDA
-
-
-
-
-
-
-
MIMEDX Announces First Quarter 2026 Operating & Financial Results
-
-
-
-
-
-
-
MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel
-
-
-
-
-
-
-
MIMEDX Announces Third Quarter 2024 Operating and Financial Results
-
-
-
-
-
-
-
MIMEDX Announces First Quarter 2024 Operating and Financial Results
-
-
-
-
-
-
-
MediWound (MDWD) Collaborates with MIMEDX (MDXG) on EscharEx Phase III Study
-
-
-
-
-
-
-
MIMEDX Announces Second Quarter 2022 Operating and Financial Results
-
-
-
-
-
-
-
MiMedx Group (MDXG) Outlines 2022 Key Strategic Milestones
-
334,509 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


